Discussion on: Impact of SLC22A1 and CYP2C9 Gene Variants on Glycemic Response to Metformin/Sulfonylurea Therapy in T2DM Patients in Port Harcourt, Nigeria

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title

Impact of SLC22A1 and CYP2C9 Gene Variants on Glycemic Response to Metformin/Sulfonylurea Therapy in T2DM Patients in Port Harcourt, Nigeria

Authored by

Reuben, I. 

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Rivers State University, Port Harcourt, Rivers State, Nigeria.

Tamuno-Emine, D.G.

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Rivers State University, Port Harcourt, Rivers State, Nigeria.

Nwachuku, E.O.

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Rivers State University, Port Harcourt, Rivers State, Nigeria.

Bartimaeus, E.S.

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Rivers State University, Port Harcourt, Rivers State, Nigeria.

DOI or Article Link

https://doi.org/10.9734/ajbgmb/2024/v16i12427

Leave a Comment